Cardiac sarcoidosis with extensive and heterogeneous left ventricular FDG uptake in absence of guidelines indication for an implantable defibrillator: Ventricular tachycardia precipitated by immunosuppressive therapy, should we have done differently?

Documenti analoghi

• Patients with a high defibrillation threshold: Approaches to management
  di: Alejandro Vidal Margenat, et al.
  Pubblicazione: (2024)
• A wide complex tachycardia in bigeminy
  di: Sudipta Mondal, et al.
  Pubblicazione: (2024)
• Wide QRS tachycardia: What is the mechanism?
  di: Krishna Kishore Umapathi, et al.
  Pubblicazione: (2024)
• Disparities in the implantation of secondary prevention implantable cardioverter defibrillator in the United States
  di: Ahmed Maraey, et al.
  Pubblicazione: (2024)
• Patient characteristics, predictors and outcome of pacemaker patients upgraded to an implantable cardioverter defibrillator
  di: Samuel H. Baldinger, et al.
  Pubblicazione: (2024)